Bipolar Disorder Treatment Market will achieve USD 5.7 billion by 2030 : GreyViews
Bipolar Disorder Treatment Market Size By Drug Class (Antidepressant Drugs, Mood Stabilizers, Antipsychotic Drugs, Antianxiety and Others), By Mechanism of Action (Beta-Blockers, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressant Drugs and Others), Regions, Segmentation, and forecast till 2030.
/EIN News/ -- Pune India, Jan. 30, 2023 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the bipolar disorder treatment market is operating and is predicted to expand soon. The manufacturers and suppliers involved in the bipolar disorder treatment market are present across various countries in the above-mentioned regions.
Get Sample Copy of This Report @ https://greyviews.com/reports/bipolar-disorder-treatment-market/485/request-sample
The report provides a detailed understanding of the market segments which have been formed by combining different prospects such as drug class, mechanism of action, and regions. Apart from this, the key driving factors, restraints, potential growth opportunities and market challenges are also discussed in the below paragraphs.
The significant players operating in the global bipolar disorder treatment market are GlaxoSmithKline plc, Johnson & Johnson, Takeda Pharmaceutical Company Limited, Allergan plc, Pfizer Inc., Janssen Pharmaceuticals, Minerva Neurosciences, Otsuka Holdings Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Novartis AG among others. To achieve a substantial market share in the worldwide bipolar disorder treatment market and strengthen their position, manufacturers are pursuing expansion methods such as current developments, mergers and acquisitions, product innovations, collaborations, and partnerships, joint ventures.
People who suffer from bipolar disorder experience periods of unusually intense emotion, irregular sleep patterns, abnormal levels of activity, and mood episodes. The healthcare provider usually conducts a mental health evaluation for the diagnosis of bipolar disorder based on the patient's symptoms, family history, and life history. It is expected that the market for bipolar disorder treatment will grow due to increasing prevalence and innovations that work with exact recognition of the mental state of a patient. As an example, tricyclic antidepressants have seen a decline over the years because they cause a higher rate of secondary effects compared to other medications used to treat the disorder. There are some factors which are hindering the growth of the market such as side effects associated with the treatment medications and a lack of skilled medical professionals. In the forecast period, factors that could slow down bipolar disorder treatment demand are rising awareness among the general population about the side effects of long-term use of bipolar disorder drugs, as well as increasing patient demand for chemical-free bipolar disorder medications. Moreover, a number of technological advancements are also contributing to the market expansion for bipolar disorder drugs and treatments, as smartphones, wearable devices etc. can be used to detect a patient's emotional and mental state, as well as capture physiological, and behavioural data.
Enquiry Before Buying This Report @ https://greyviews.com/inquiry/485
Scope of Bipolar Disorder Treatment Market Report:
| Report Metric | Information |
| Study Period | 2022-2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Market Share Unit | USD Billion |
| Segments Covered | Drug Class, Mechanism of Action, and Regions. |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle-East and Africa |
| Major Players | GlaxoSmithKline plc, Johnson & Johnson, Takeda Pharmaceutical Company Limited, Allergan plc, Pfizer Inc., Janssen Pharmaceuticals, Minerva Neurosciences, Otsuka Holdings Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Novartis AG among others |
Segmentation Analysis
Antipsychotic drugs are expected to be the fastest-growing segment in 2022.
The drug class segment includes antidepressant drugs, mood stabilizers, antipsychotic drugs, antianxiety and others. The antipsychotic drugs segment is expected to witness the highest growth rate during the forecast period Among all bipolar disorder treatments, antipsychotic drugs accounted for the largest percentage of revenue. It is a combination therapy in which an SSRI is used alongside an antipsychotic. The treatment has been extremely successful, which has led more doctors to prescribe it. To control insane side effects, like hallucinations and mania symptoms, antipsychotic drugs are used as a momentary treatment for bipolar disorder.
Selective serotonin reuptake inhibitors are expected to be the fastest-growing segment in 2022.
The mechanism of the action segment includes beta-blockers, selective serotonin reuptake inhibitors, tricyclic antidepressant drugs and others. The selective serotonin reuptake inhibitors are expected to witness the highest growth rate during the forecast period. It has been proposed that the helpful actions of SSRIs are derived from expanding the lack of serotonin, one of the main causes of depression, by inhibiting serotonin reuptake, resulting in the development of serotonin action. SSRIs have a significant influence on different synapses, such as dopamine or norepinephrine
Regional Analysis
The regional analysis provides a detailed perception of the key regions and the countries. Some of the key countries analyzed for the bipolar disorder treatment market include the US, Canada, Mexico, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Brazil, Peru, UAE, South Africa, and Saudi Arabia.
The North American region witnessed a major share. The bipolar disorder treatment market is expected to grow the fastest in North America during the forecast period, which is attributed to high levels of anxiety, short sleep, and substance abuse patterns among the population. There is a considerable share of the bipolar disorder drugs and treatment market in North America, and this is expected to continue over the projection period, with occasional fluctuations.
Country Analysis
- Germany
Germany's bipolar disorder treatment market size was valued at USD 0.33 billion in 2022 and is expected to reach USD 0.43 billion by 2030, at a CAGR of 3.4% from 2023 to 2030.
Genetic research on bipolar disorder has been developed through technological advances, which have further increased the market. Growing awareness about bipolar disorders has also led to a growing number of mergers and acquisitions among drug manufacturing companies, which is fueling the country's growth market.
- China
China’s bipolar disorder treatment market size was valued at USD 0.34 billion in 2022 and is expected to reach USD 0.45 billion by 2030, at a CAGR of 3.6% from 2023 to 2030.
Growth is driven by the development of healthcare infrastructure, an increase in government initiatives to promote awareness in underserved areas, and a greater rate of strategic collaboration among market players.
- India
India's bipolar disorder treatment market size was valued at USD 0.26 billion in 2022 and is expected to reach USD 0.34 billion by 2030, at a CAGR of 3.5% from 2023 to 2030.
By conducting research studies and developing new medications for bipolar disorder drug therapy, scientific organizations and medical institutions are also actively engaged in treating bipolar disorder, positively impacting the country’s market growth.
Covid-19 Impact
Covid-19 had a major impact on almost all industries, such as electronics, semiconductors, manufacturing, automobile, etc. However, several companies operating in the technology sector have seen increased revenue due to significant changes in consumer preferences toward technological services. In addition, the pandemic has led to significant growth in technology across developing and developed countries.
Furthermore, the growth of this market is mainly driven owing to the rising awareness among patients and society about the management of the bipolar disorder.
Buy Now Full Report @ https://greyviews.com/checkout/485/single_user_license
Contact Us
Rocky Shah
GreyViews
Pune India
Phone: (+44) 162-237-1047
Email: sales@greyviews.com
Browse Related Reports:
Enteral Syringe Market Size By Product Type (Catheter Tip Syringes, Single Use Enteral Syringes, Home Use Enteral Syringes, and Others), By Application (Neurological Disease, Oncology, GI Related Disease, Malnutrition, and Others), By Patient Group (Adults and Neonatal & Pediatrics), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/enteral-syringe-market/492
Disposable Pipette Tips Market Size by Type (Non-Filtered Tips and Filtered Tips), By Technology (Automatic and Manual), By End-User (Academic & Research Institutes, Pharma & Biotech Companies, Hospitals and Others), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/disposable-pipette-tips-market/489
Bipolar Disorder Treatment Market Size By Drug Class (Antidepressant Drugs, Mood Stabilizers, Antipsychotic Drugs, Antianxiety and Others), By Mechanism of Action (Beta-Blockers, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressant Drugs and Others), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/bipolar-disorder-treatment-market/485
Catheter Market Size By Product (Urology Catheters, Neurovascular Catheters, Intravenous Catheters, Cardiovascular Catheters, and Others), By End-User (Long Term Care Facilities, Hospitals, and Others), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/catheter-market/479
Cardiovascular Needle Market Size By Type (Cutting Needles and Round Bodied Needles), By Application (Cardiac Valve Procedures, Open-Heart Surgery, Heart Transplant, Coronary Artery Bypass Graft Surgery, and Others), By Usage (Multiple Use and Single Use), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/cardiovascular-needle-market/477
Biomedical Sensors Market Size By Type (Wired and Wireless), By Sensor Type (Biochemical Image Sensors, Temperature, Pressure, and Others), By Industry (Pharmaceutical, Healthcare, and Others), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/biomedical-sensors-market/475
Veterinary Hematology Analyzers Market Size By Product Type (Table Top Analyzers (Fully Automatic Analyzers and Semiautomatic Analyzers) and Point of Care Analyzers (Cartridge-Based Analyzers and Direct Sample Based Analyzers), By Analysis Parameter (2-Part WBC Differential, 3-Part WBC Differential, 5-Part WBC Differential, and Others), By End-User (Research institutes, Veterinary hospitals and clinics, Veterinary diagnostic centers, point-of-care testing, inhouse-testing, and others), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/veterinary-hematology-analyzers-market/469
Structural Heart Devices Market Size By Indication (Atrial Septal Defects, Aortic Valvular Disease, Pulmonary Valvular Disease, Patent Foramen Ovale, Ventricular Septal Defects, Mitral Valvular Disease, Patent Ductus Arteriosus, and Others), By Product Type (Heart Valve Devices, Annuloplasty Rings, Occluders and Delivery Systems, Transcatheter Mitral Valve Repair, and Others), By Procedure(Repair and Replacements), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/structural-heart-devices-market/467
Shoulder Arthroplasty Market Size By Indication (Arthritis, Fracture/Dislocation, Rotator Cuff Tear Arthropathy, Hill Sachs Defect, and Others), By Device (Shoulder Arthroplasty Resurfacing Implants, Shoulder Arthroplasty Trauma Devices, and Shoulder Arthroplasty Platform Systems), By Procedure (Partial Shoulder Arthroplasty, Total Shoulder Arthroplasty, Reverse Shoulder Arthroplasty, and Revision Shoulder Arthroplasty), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/shoulder-arthroplasty-market/466
Radiopharmaceuticals Market Size By Procedural Volume (Diagnostic Producers and Therapeutic Procedures), By Application (Endocrinology, Oncology, Neurology, Cardiology, and Others), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/radiopharmaceuticals-market/465
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
